ROBOTERA

Based in China, ROBOTERA operates as an embodied AI and robotics company specializing in the development of humanoid robots, dexterous robotic hands, and full-stack robotics systems. The company focuses on integrating proprietary hardware and AI software to deliver intelligent robotic solutions for research, industrial, and commercial applications. Based in Beijing, China and founded in 2023, Beijing Xingdong Era Technology Co. , Ltd.

(ROBOTERA), was founded by Chen Jianyu. The company provides humanoid robots, dexterous robotic hands, embodied AI models, and robotics software for the robotics and embodied intelligence industry. The company was incubated at Tsinghua University's Institute for Interdisciplinary Information Sciences and focuses on developing fully integrated software and hardware systems for general-purpose intelligent robots. In July 2026, ROBOTERA raised CNY 1 billion in venture funding led by CCT Fund Management, with participation from Jiangxi Financial Investment Private Equity Funds Mangement, Guoyuan Equity Investment, Chongqing Yufu Holding, HangZhou Capital, China International Capital Corporation, Ubiquant Investment, Hony Capital, Jun Tai Capital, Shenghe Capital, Houxue Capital, Qingkong Tiancheng Asset Management, Qianshan Capital.

Other unspecified investors also participated in this round. ROBOTERA's main products include full-size bipedal humanoid robot with 20 kg dual-arm payload and 4m/s running speed, intelligent service robot designed for service and research applications and robotic five-finger dexterous hands with advanced manipulation capabilities. The company's intelligent general-purpose humanoid robots, integrated with Artificial General Intelligence (AGI), are adaptable to a wide range of fields and scenarios such as manufacturing work, logistics, warehousing and material handling, commercial services, domestic care, etc. ROBOTERA generates revenue through the sale of humanoid robots, service robots, robotic workstations, and dexterous robotic hands designed for research, industrial, and commercial applications.

The company also earns income from supplying proprietary robotics components, including actuators, joints, and manipulation systems, as well as from providing embodied AI and full-stack robotics solutions that integrate advanced software, AI models, and hardware platforms. The company will use the funding in July 2026 to accelerate technology iteration and product scale-up, with a focus on e-commerce logistics, industrial manufacturing, and pharmaceutical distribution.